$HLTHQ
Cue Health Inc. Stock $hlthq

$hlthq Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000162894522000104 Filed on August 10, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$69.59M	$87.70M	$179.4M
YoY Change	-68.89%	-36.18%	178.16%
Cost Of Revenue	$50.60M	$101.9M	$86.70M
YoY Change	-42.88%	19.63%
Gross Profit	$18.99M	-$14.20M	$92.71M
YoY Change	-85.94%	-112.16%
Gross Profit Margin	27.29%	-16.19%	51.68%
Selling, General & Admin	$43.75M	$42.38M	$61.08M
YoY Change	13.19%	228.26%	396.57%
% of Gross Profit	230.36%		65.88%
Research & Development	$42.52M	$44.00M	$28.79M
YoY Change	368.29%	843.8%	288.54%
% of Gross Profit	223.84%		31.05%
Depreciation & Amortization	$8.300M	$10.20M	$10.61M
YoY Change	-27.19%	27.5%	117.16%
% of Gross Profit	43.7%		11.44%
Operating Expenses	$86.27M	$86.38M	$89.87M
YoY Change	80.73%	391.56%	355.96%
Operating Profit	-$67.41M	-$102.5M	$2.848M
YoY Change	-177.15%	-258.35%	-80.7%
Interest Expense	-$346.0K	-$16.00K	-$51.00K
YoY Change	-80.63%	-99.83%	-90.47%
% of Operating Profit			-1.79%
Other Income/Expense, Net	$409.0K	$43.00K	$6.000K
YoY Change	-611.25%	79.17%	-83.78%
Pretax Income	-$67.35M	-$102.4M	$2.803M
YoY Change	-236.21%	-421.53%	-80.34%
Income Tax	-$1.047M	-$3.386M	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$66.30M	-$99.05M	$2.803M
YoY Change	-442.69%	-600.03%	-78.49%
Net Earnings / Revenue	-95.28%	-112.94%	1.56%
Basic Earnings Per Share	-$0.45	-$0.67	$0.02
Diluted Earnings Per Share	-$0.45	-$0.67	$0.02
COMMON SHARES
Basic Shares Outstanding	148.1M shares	147.5M shares	146.5M shares
Diluted Shares Outstanding	148.3M shares	147.5M shares	153.0M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$304.7M	$363.1M	$426.5M
YoY Change	-31.78%	47.42%
Cash & Equivalents	$304.7M	$363.1M	$426.5M
Short-Term Investments
Other Short-Term Assets	$13.44M	$12.19M	$9.807M
YoY Change	543.73%	-71.4%
Inventory	$133.3M	$139.0M	$132.6M
Prepaid Expenses	$44.36M	$50.44M	$42.90M
Receivables	$24.78M	$54.01M	$75.83M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$521.9M	$620.1M	$701.4M
YoY Change	-22.05%	58.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$279.5M	$276.1M	$267.0M
YoY Change	13.09%	20.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.577M	$6.902M	$5.679M
YoY Change	438.52%	7.61%
Total Long-Term Assets	$303.2M	$293.9M	$282.4M
YoY Change	20.09%	23.07%
TOTAL ASSETS
Total Short-Term Assets	$521.9M	$620.1M	$701.4M
Total Long-Term Assets	$303.2M	$293.9M	$282.4M
Total Assets	$825.0M	$914.1M	$983.8M
YoY Change	-10.52%	44.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$32.52M	$38.35M	$48.84M
YoY Change	-7.47%	48.51%
Accrued Expenses	$55.46M	$83.50M	$47.40M
YoY Change	83.82%	122.11%
Deferred Revenue	$84.90M	$85.58M	$84.63M
YoY Change	11.21%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.581M	$2.605M	$2.620M
YoY Change		93.11%
Total Short-Term Liabilities	$175.5M	$210.0M	$191.7M
YoY Change	-3.4%	32.5%
LONG-TERM LIABILITIES
Long-Term Debt	$1.268M	$1.990M	$2.627M
YoY Change	-66.99%	-99.24%
Other Long-Term Liabilities	$3.828M	$4.943M	$6.356M
YoY Change	333.03%	-94.84%
Total Long-Term Liabilities	$3.828M	$4.943M	$6.356M
YoY Change	333.03%	-98.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$175.5M	$210.0M	$191.7M
Total Long-Term Liabilities	$3.828M	$4.943M	$6.356M
Total Liabilities	$235.1M	$273.7M	$258.6M
YoY Change	-12.16%	-46.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$186.6M	-$120.3M	-$21.22M
YoY Change	220.3%
Common Stock	$1.000K	$1.000K	$1.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$590.0M	$640.4M	$725.1M
YoY Change
Total Liabilities & Shareholders Equity	$825.0M	$914.1M	$983.8M
YoY Change	-10.52%	44.79%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$66.30M	-$99.05M	$2.803M
YoY Change	-442.69%	-600.03%	-78.49%
Depreciation, Depletion And Amortization	$8.300M	$10.20M	$10.61M
YoY Change	-27.19%	27.5%	117.16%
Cash From Operating Activities	-$39.91M	-$51.83M	$31.52M
YoY Change	-304.51%	37.08%	-189.77%
INVESTING ACTIVITIES
Capital Expenditures	-$18.27M	-$20.63M	$12.78M
YoY Change	-5.19%	-64.98%	-58.08%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$18.27M	-$20.63M	-$14.06M
YoY Change	-5.19%	-64.98%	-55.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$0.00
YoY Change			-100.0%
Cash From Financing Activities	-296.0K	-3.388M	-$873.0K
YoY Change	-100.14%	-101.54%	-101.54%
NET CHANGE
Cash From Operating Activities	-39.91M	-51.83M	$31.52M
Cash From Investing Activities	-18.27M	-20.63M	-$14.06M
Cash From Financing Activities	-296.0K	-3.388M	-$873.0K
Net Change In Cash	-58.47M	-75.85M	$16.59M
YoY Change	-128.35%	-161.63%	-260.89%
FREE CASH FLOW
Cash From Operating Activities	-$39.91M	-$51.83M	$31.52M
Capital Expenditures	-$18.27M	-$20.63M	$12.78M
Free Cash Flow	-$21.64M	-$31.21M	$18.74M
YoY Change	-155.81%	-248.01%	-128.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001628945
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40590
	dei	Entity Registrant Name EntityRegistrantName	Cue Health Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.00001 per share
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1562193
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4980 Carroll Canyon Rd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	City Area Code CityAreaCode	858
	dei	Local Phone Number LocalPhoneNumber	412-8151
	dei	Trading Symbol TradingSymbol	HLTH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	148073100	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	363124000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	409873000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1334000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	13837000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	54008000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	104589000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	139047000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	88388000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	50436000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45889000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	12186000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7446000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	620135000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	670022000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	190131000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	177456000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85971000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79474000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10936000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7673000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6902000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5435000	usd
CY2022Q2	us-gaap	Assets Assets	914075000	usd
CY2021Q4	us-gaap	Assets Assets	940060000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	38351000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	37208000	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	75820000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	29498000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8297000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	85576000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	82165000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7679000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7147000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2605000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2621000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	210031000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	166936000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10283000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10283000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46455000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46464000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1990000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3271000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4943000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6356000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	273702000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	233310000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	147834377	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	147834377	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146402991	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	146402991	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	760637000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	730767000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-120265000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24018000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	640373000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	706750000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	914075000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	940060000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	87700000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	137423000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	267110000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	201922000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16971000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1529000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	51139000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1959000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44000000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4662000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72787000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12071000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25411000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11382000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52321000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23252000	usd
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	1883000	usd
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	1883000	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	190163000	usd
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	72715000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	366725000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	122459000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-102463000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	64708000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-99615000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	79463000	usd
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-16000	usd
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9429000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-67000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9964000	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	190000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	190000	usd
CY2022Q2	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	usd
CY2021Q2	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-23254000	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-99633000	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-23254000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	24000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	49000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	61000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-102436000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	31859000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	46116000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3386000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12050000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3386000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13276000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-99050000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19809000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-96247000	usd
	us-gaap	Net Income Loss NetIncomeLoss	32840000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147498162	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18822474	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147014951	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18617247	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147498162	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26241564	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147014951	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26036337	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	725138000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	242000	usd
CY2022Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2749000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16792000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-99050000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	640373000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-85270000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	227000	usd
CY2021Q2	hlth	Stock Issued During Period Value Common Stock Warrants Exercised StockIssuedDuringPeriodValueCommonStockWarrantsExercised	77000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1239000	usd
CY2021Q2	hlth	Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions	17000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2569000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19809000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-61332000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	706750000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	512000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3468000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32826000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-96247000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	640373000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-101400000	usd
	hlth	Stock Issued During Period Value Common Stock Warrants Exercised StockIssuedDuringPeriodValueCommonStockWarrantsExercised	77000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	258000	usd
	hlth	Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions	63000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1239000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5591000	usd
	us-gaap	Net Income Loss NetIncomeLoss	32840000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-61332000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-96247000	usd
	us-gaap	Net Income Loss NetIncomeLoss	32840000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21585000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14500000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	190000	usd
	hlth	Change In Fair Value Of Convertible Notes ChangeInFairValueOfConvertibleNotes	0	usd
	hlth	Change In Fair Value Of Convertible Notes ChangeInFairValueOfConvertibleNotes	-23254000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	32826000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6830000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1998000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4017000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1822000	usd
	hlth	Convertible Notes Issuance Costs ConvertibleNotesIssuanceCosts	0	usd
	hlth	Convertible Notes Issuance Costs ConvertibleNotesIssuanceCosts	6000000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2214000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	588000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	176000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	230000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	30581000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	0	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	12263000	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	0	usd
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-50581000	usd
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	36109000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	81240000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	26421000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5990000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	22818000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1094000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	676000	usd
	hlth	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	7853000	usd
	hlth	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	0	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32428000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11473000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-11546000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3411000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-42602000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2089000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8911000	usd
	hlth	Increase Decrease In Finance Lease Interest Expense IncreaseDecreaseInFinanceLeaseInterestExpense	94000	usd
	hlth	Increase Decrease In Finance Lease Interest Expense IncreaseDecreaseInFinanceLeaseInterestExpense	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20311000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-37812000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30781000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56545000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3899000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2351000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-34680000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58896000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3468000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	685000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	235480000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	512000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	258000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	77000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1610000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	82250000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	hlth	Payments Of Financing Costs Excluding Convertible Notes Debt Issuance Costs PaymentsOfFinancingCostsExcludingConvertibleNotesDebtIssuanceCosts	599000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129255000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364458000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	252326000	usd
	hlth	Payments Of Financing Costs Excluding Convertible Notes Debt Issuance Costs PaymentsOfFinancingCostsExcludingConvertibleNotesDebtIssuanceCosts	2128000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	87684000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1391000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	864000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4261000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	219779000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-59252000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	123071000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	423710000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	363124000	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	246326000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1334000	usd
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	6000000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	364458000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	252326000	usd
	us-gaap	Interest Paid Net InterestPaidNet	23000	usd
	us-gaap	Interest Paid Net InterestPaidNet	760000	usd
	hlth	Early Exercised Stock Options Liability EarlyExercisedStockOptionsLiability	0	usd
	hlth	Early Exercised Stock Options Liability EarlyExercisedStockOptionsLiability	63000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2611000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	38717000	usd
	hlth	Prepaid Rent Reclassified To Right Of Use Assets PrepaidRentReclassifiedToRightOfUseAssets	50000	usd
	hlth	Prepaid Rent Reclassified To Right Of Use Assets PrepaidRentReclassifiedToRightOfUseAssets	15966000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8150000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	11618000	usd
	hlth	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	0	usd
	hlth	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	2301000	usd
	hlth	Software Development Costs Incurred But Not Yet Paid SoftwareDevelopmentCostsIncurredButNotYetPaid	704000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
	hlth	Software Development Costs Incurred But Not Yet Paid SoftwareDevelopmentCostsIncurredButNotYetPaid	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying unaudited interim condensed financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to revenue recognition, net accounts receivable, equity-based compensation expense, product warranty reserve, the usage and recoverability of its inventories and long-lived assets and net deferred tax assets (and related valuation allowance). The </span></div>Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	30600000	usd
CY2022Q2	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	30600000	usd
CY2022Q2	hlth	Product Warranty Reserve ProductWarrantyReserve	12300000	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	12300000	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1600000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1100000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	92448000	usd
	hlth	Contract With Customer Liability Unearned Revenue From Cash Received During The Period ContractWithCustomerLiabilityUnearnedRevenueFromCashReceivedDuringThePeriod	3411000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	95859000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	800000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	300000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	87092000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	46273000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	11218000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	10920000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	73670000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	33863000	usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	32933000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2668000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	139047000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	88388000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	42800000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	30600000	usd
CY2022Q2	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	30600000	usd
CY2022Q2	hlth	Product Warranty Reserve ProductWarrantyReserve	12300000	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	12300000	usd
CY2022Q2	hlth	Prepaid Expense Excluding Prepaid Inventory Current PrepaidExpenseExcludingPrepaidInventoryCurrent	34720000	usd
CY2021Q4	hlth	Prepaid Expense Excluding Prepaid Inventory Current PrepaidExpenseExcludingPrepaidInventoryCurrent	30153000	usd
CY2022Q2	hlth	Prepaid Inventory Current PrepaidInventoryCurrent	15716000	usd
CY2021Q4	hlth	Prepaid Inventory Current PrepaidInventoryCurrent	15736000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	50436000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45889000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	252026000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	219125000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	61895000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	41669000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	190131000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	177456000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	10200000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	8000000	usd
	us-gaap	Depreciation Depreciation	20200000	usd
	us-gaap	Depreciation Depreciation	12800000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8500000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9800000	usd
CY2022Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	13582000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5638000	usd
CY2022Q2	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	3408000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2067000	usd
CY2022Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	10174000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	3571000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10936000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7673000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1700000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85971000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79474000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8543000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9821000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7679000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7147000	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2605000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2621000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46455000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46464000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1990000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3271000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	2795000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	388000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5557000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2967000	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	640000	usd
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	80000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1279000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	706000	usd
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	43000	usd
CY2021Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	18000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	94000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	100000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	3478000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	486000	usd
	us-gaap	Lease Cost LeaseCost	6930000	usd
	us-gaap	Lease Cost LeaseCost	3773000	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4284000	usd
CY2022Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	15812000	usd
CY2022Q2	hlth	Accrued Liabilities Purchases Current AccruedLiabilitiesPurchasesCurrent	20374000	usd
CY2021Q4	hlth	Accrued Liabilities Purchases Current AccruedLiabilitiesPurchasesCurrent	285000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19144000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13693000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10835000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6371000	usd
CY2022Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	8011000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4865000	usd
CY2022Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1644000	usd
CY2021Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	75820000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	29498000	usd
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	297800000	usd
CY2021Q3	hlth	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	550000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9163160	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	515705	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.55
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	133951	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	13.24
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	49766	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	13.99
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8463738	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.23
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M14D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6203101	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.20
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M10D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	8463738	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y3M14D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-99050000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	19809000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-96247000	usd
	us-gaap	Net Income Loss NetIncomeLoss	32840000	usd
CY2022Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2021Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	17087000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	28565000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-99050000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2722000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-96247000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4275000	usd
CY2022Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
CY2021Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	838000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	1332000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-99050000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3560000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-96247000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5607000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147498162	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18822474	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147014951	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18617247	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147498162	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26241564	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147014951	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26036337	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.65
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.65
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	300000	usd
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25440413	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2838421	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25440413	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2838421	shares
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.033
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.034
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.378
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.288
	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1700000	usd
	hlth	Standard Product Warranty Term StandardProductWarrantyTerm	P12M
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	1900000	usd
	us-gaap	Restructuring Charges RestructuringCharges	1900000	usd
CY2022Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1600000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4865000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	6496000	usd
	hlth	Standard Product Warranty Accrual Increase Due To Inventory Charge StandardProductWarrantyAccrualIncreaseDueToInventoryCharge	12263000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	7812000	usd
CY2022Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	15812000	usd
CY2021Q4	hlth	Number Of Letters Of Credit In Effect NumberOfLettersOfCreditInEffect	1	letter_of_credit
CY2021Q4	hlth	Number Of Letters Of Credit In Effect NumberOfLettersOfCreditInEffect	1	letter_of_credit
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	800000	usd

Files In Submission

Name	View Source	Status
0001628945-22-000104-index-headers.html	Edgar Link	pending
0001628945-22-000104-index.html	Edgar Link	pending
0001628945-22-000104.txt	Edgar Link	pending
0001628945-22-000104-xbrl.zip	Edgar Link	pending
exhibit31106302210-q.htm	Edgar Link	pending
exhibit31206302210-q.htm	Edgar Link	pending
exhibit32106302210-q.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hlth-20220630.htm	Edgar Link	pending
hlth-20220630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hlth-20220630_cal.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
hlth-20220630_lab.xml	Edgar Link	unprocessable
hlth-20220630_pre.xml	Edgar Link	unprocessable
hlth-20220630_htm.xml	Edgar Link	completed
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
hlth-20220630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HLTHQ
Cue Health Inc. Stock $hlthq

2022 Q3 Form 10-Q Financial Statement

#000162894522000104 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLTHQ Cue Health Inc. Stock $hlthq

2022 Q3 Form 10-Q Financial Statement

#000162894522000104 Filed on August 10, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLTHQ
Cue Health Inc. Stock $hlthq